Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 10Leukemia 8Congenital Abnormalities 8Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelomonocytic, Chronic 5Myeloproliferative Disorders 4Leukemia, Myeloid, Chronic-Phase 4Thrombocythemia, Essential 3Polycythemia Vera 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Primary Myelofibrosis 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Chromosome 5q Deletion Syndrome 2Burkitt Lymphoma 2

Interventions

Cyclophosphamide 71Peripheral Blood Stem Cell Transplantation 65fludarabine phosphate 62Tacrolimus 47Busulfan 47Mycophenolic Acid 39Methotrexate 39Antilymphocyte Serum 39Cyclosporine 38Whole-Body Irradiation 34Filgrastim 34Radiotherapy 32Melphalan 24Methylprednisolone 23Cord Blood Stem Cell Transplantation 22Etoposide 17Cytarabine 16Thiotepa 12Flow Cytometry 12sargramostim 10merphos 10Therapeutics 10Sirolimus 9Rituximab 9Psychiatric Rehabilitation 8Imatinib Mesylate 7thymoglobulin 6Transplantation 6Polymerase Chain Reaction 6Granulocyte Colony-Stimulating Factor 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Accelerated Phase × Cytogenetic Analysis × Clear all
NCT00816413 2023-08-14

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

University of Nebraska

Phase 1/2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Blast Crisis, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00816283 2012-07-17

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Completed
5 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡